Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


President Signs FDA User Fee Legislation


 
Sen. Lamar Alexander

On Aug. 18, President Donald Trump signed bipartisan legislation authored by Senate health committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.) intended to speed safe drugs and medical devices into patients' medicine cabinets and doctors' offices, while maintaining safety and effectiveness standards.

"The legislation signed by the president today will speed the FDA's work to review new cures and treatments and get them into patients' medicine cabinets and doctors' offices," Alexander said after the legislation was signed. "The first step was last year's passage of 21st Century Cures to spur medical research, and this is the next step -- legislation to help ensure that these breakthroughs in research make it to patients."

"I'm pleased that Democrats and Republicans in Congress were able to set aside partisanship, work together to put patients and families first, and ensure the FDA continues to have the resources it needs to advance safe, effective medical products for people across the country," Murray said. "This legislation reflects years of hard work by the Obama Administration, as well as members on both sides of the aisle, and I want to express my appreciation in particular to Chairman Alexander for his leadership. I hope we can build on this step forward with additional efforts to strengthen healthcare for the communities we all serve."

The legislation was passed by the Senate on Aug. 3 by a vote of 94-1.

The legislation includes four different user fee agreements that must be reauthorized by Sept. 30. The bill is virtually identical to legislation overwhelmingly approved by the Senate's health committee on May 11. This legislation will reauthorize the authority for the Food and Drug Administration (FDA) to accept user fees - paid by manufacturers of drugs and medical devices - that account for $8 to $9 billion over 5 years and is over a quarter of all FDA funding. The reauthorizations are based on recommendations from industry and FDA after a public process.

Over the last two years, the HELP Committee led by Alexander and Murray has held 15 bipartisan briefings, including some with the House Energy and Commerce Committee, to hear from FDA and industry about the reauthorization. The HELP Committee held two bipartisan hearings, on March 21 and April 4, on the medical device and drug user fees. The committee held a markup on the bill on May 11, when two bipartisan amendments were adopted, and the committee overwhelmingly approved the bill -- voting 21 to 2.

 
Share:

Related Articles:


Recent Articles

Trump Picks Supreme Court Nominee

President Donald Trump announced his pick to replace Justice Kennedy on Monday evening, July 9. He selected 53-year-old Judge Brett Kavanaugh to serve on the Supreme Court, pending Congressional approval.

Read More

Before Stage Four

Providers wouldn't wait to intervene with breast cancer until it had become metastatic. Yet, delayed reaction is too often the case when it comes to suicide prevention efforts.

Read More

Nashville Fosters Innovation at Startup Day Event

The Department of Health and Human Services (HHS) is looking to invest in innovative healthcare startups, according to an official who attended the Startup Day Nashville in June.

Read More

MHAMT Leader Takes on National Role

MHA of Middle Tennessee leader Tom Starling was inducted as board chair of the national Mental Health America organization at last month's annual meeting.

Read More

The Opioid Crisis - Where Do We Go From Here?

As discussed in last month's edition of the Nashville Medical News, the Tennessee General Assembly recently approved a significant portion of Governor Bill Haslam's "TN Together" plan to combat the opioid crisis in Tennessee.

Read More

The Opioid Crisis - Where Do We Go From Here?

As discussed in last month's edition of the Nashville Medical News, the Tennessee General Assembly recently approved a significant portion of Governor Bill Haslam's "TN Together" plan to combat the opioid crisis in Tennessee.

Read More

Op-Ed: The Need for Effective Measures to Treat Mental Illness

There is an urgent need for more dynamic and effective measures to care for the growing number of Americans with serious mental illness - in Middle Tennessee and across the nation.

Read More

Behavioral Health Rounds

Read More

SAFE Clinic Opens to Victims of Sexual Violence

Nashville's first freestanding SAFE Clinic is a dedicated, healing environment for rape victims.

Read More

AAC Utilizing AI to Improve Outcomes

Artificial intelligence helping staff, patients at AAC

Read More

Email Print
 
 

 

 


Tags:
FDA, Food & Drug Administration, HELP Committee, Lamar Alexander, Patty Murray, U.S. Senate
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: